Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
26.36
-0.75 (-2.77%)
May 14, 2026, 4:00 PM EDT
SHA:688351 Revenue
Shanghai MicroPort EP MedTech had revenue of 125.93M CNY in the quarter ending March 31, 2026, with 20.97% growth. This brings the company's revenue in the last twelve months to 486.36M, up 13.61% year-over-year. In the year 2025, Shanghai MicroPort EP MedTech had annual revenue of 464.53M with 12.43% growth.
Revenue (ttm)
486.36M
Revenue Growth
+13.61%
P/S Ratio
25.51
Revenue / Employee
929.94K
Employees
523
Market Cap
12.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 464.53M | 51.37M | 12.43% |
| Dec 31, 2024 | 413.17M | 83.97M | 25.51% |
| Dec 31, 2023 | 329.19M | 68.87M | 26.46% |
| Dec 31, 2022 | 260.32M | 70.30M | 36.99% |
| Dec 31, 2021 | 190.03M | 48.74M | 34.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Weigao Blood Purification Products | 3.78B |
| Cofoe Medical Technology | 3.66B |
| Double Medical Technology | 2.69B |
| SonoScape Medical | 2.36B |
| Qingdao Haier Biomedical Co.,Ltd | 2.29B |
| Jafron Biomedical | 2.02B |
| Shandong Weigao Orthopaedic Device | 1.53B |
| Shanghai MicroPort Endovascular MedTech | 1.39B |